InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Wettig Thane, Directeur Commercial. Insider active across 1 companies, notably FIBROGEN INC. Cumulatively, 13 filings have been logged. Total volume traded: €61k. The latest transaction was disclosed on 22 June 2022 — Retenue fiscale. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations13 total
€7,081655 shares@ €10.81022.9% of flow
Common Stock
SEC:0001209191-22-039295:0·
€3,199360 shares@ €8.88561.3% of flow
Common Stock
SEC:0001209191-22-035217:0·
€7,913655 shares@ €12.08113.2% of flow
Common Stock
SEC:0001209191-22-021000:0·
€19,9081,706 shares@ €11.66958.2% of flow
Common Stock
SEC:0001209191-22-017653:0·
045,000 shares0
Common Stock
SEC:0001209191-22-010459:0·
€6,857517 shares@ €13.26246.7% of flow
Common Stock
SEC:0001209191-21-071114·
€6,857517 shares@ €13.26242.8% of flow
Common Stock
SEC:0001209191-21-071114:0·
€5,400620 shares@ €8.715.3% of flow
Common Stock
SEC:0001209191-21-057566·
€5,400620 shares@ €8.712.2% of flow
Common Stock
SEC:0001209191-21-057566:0·
€30,4033,100 shares@ €9.807429.6% of flow
Common Stock
SEC:0001209191-21-053980·
Ideal exit: 23 May 2022 (T+270)
€30,4033,100 shares@ €9.807412.5% of flow
Common Stock
SEC:0001209191-21-053980:0·
Ideal exit: 23 May 2022 (T+270)
€60,0642,593 shares@ €23.163858.5% of flow
Common Stock
SEC:0001209191-21-043157·
€60,0642,593 shares@ €23.163824.7% of flow
Common Stock
SEC:0001209191-21-043157:0·
13 of 13 declarations
About Wettig Thane
Thane Wettig serves as Chief Commercial Officer at FibroGen Inc. He is responsible for leading the company's commercial activities, including business development and sales strategies. With a strong background in the industry, he plays a key role in implementing FibroGen's commercial strategy. Thane Wettig is committed to supporting the company's mission and promoting its growth.
